Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium

Aging

Volumn 6, Issue 8, 2014, Pages 661-674

  Zinovkin, Roman A ^a   Romaschenko, Valeria P ^a   Galkin, Ivan I ^a   Zakharova, Vlada V ^a   Pletjushkina, Olga Yu ^a   Chernyak, Boris V ^a   Popova, Ekaterina N ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Cell adhesion molecules; Endothelium; Mitochondrial reactive oxygen species; NF B; TNF

Indexed keywords

10-(6'-PLASTOQUINONYL)DECYLTRIPHENYLPHOSPHONIUM; ANTIOXIDANT; ICAM1 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PLASTOQUINONE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANALOGS AND DERIVATIVES; ANIMAL; AORTA; BLOOD; DRUG EFFECTS; ENDOTHELIUM CELL; INFLAMMATION; METABOLISM; MITOCHONDRION; MOUSE; PHOSPHORYLATION; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; ANTIOXIDANTS; AORTA; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MICE; MITOCHONDRIA; NF-KAPPA B; PHOSPHORYLATION; PLASTOQUINONE; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907096944     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100685     Document Type: Article

References (94)

1. Hirata Y, Nagata D, Suzuki E, Nishimatsu H, Suzuki J-i and Nagai R. Diagnosis and Treatment of Endothelial Dysfunction in Cardiovascular Disease A Review. International Heart Journal. 2010; 51:1-6.
2. Sena CM, Pereira AM and Seica R. Endothelial dysfunction-a major mediator of diabetic vascular disease. Biochim Biophys Acta. 2013; 1832:2216-2231.
3. Merat S, Fruebis J, Sutphin M, Silvestre M and Reaven PD. Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis. J Gerontol A Biol Sci Med Sci. 2000; 55:B85-94.
4. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, Carella C, Giugliano D, Varricchio M and D'Onofrio F. Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol. 1998; 275:E294-299.
5. Wajant H, Pfizenmaier K and Scheurich P. Tumor necrosis factor signaling. Cell death and differentiation. 2003; 10:45-65.
6. Baud V and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001; 11:372-377.
7. Roebuck KA and Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol. 1999; 66:876-888.
8. Kobuchi H, Roy S, Sen CK, Nguyen HG and Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol. 1999; 277:C403-411.
9. Donato AJ, Pierce GL, Lesniewski LA and Seals DR. Role of NFkappaB in age-related vascular endothelial dysfunction in humans. Aging (Albany NY). 2009; 1:678-680.
10. Kim YS, Ahn Y, Hong MH, Joo SY, Kim KH, Sohn IS, Park HW, Hong YJ, Kim JH, Kim W, Jeong MH, Cho JG, Park JC, et al. Curcumin attenuates inflammatory responses of TNF-alphastimulated human endothelial cells. J Cardiovasc Pharmacol. 2007; 50:41-49.
11. West AP, Shadel GS and Ghosh S. Mitochondria in innate immune responses. Nature reviews Immunology. 2011; 11:389-402.
12. Davidson SM and Duchen MR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res. 2007; 100:1128-1141.
13. Hughes G, Murphy MP and Ledgerwood EC. Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factorinduced apoptosis: evidence from mitochondria-targeted antioxidants. Biochem J. 2005; 389:83-89.
14. Zhang DX and Gutterman DD. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology. 2007; 292:H2023-H2031.
15. Circu ML and Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010; 48:749-762.
16. Chandel NS, Trzyna WC, McClintock DS and Schumacker PT. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol. 2000; 165:1013-1021.
17. Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY, Sack MN, Kastner DL and Siegel RM. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med. 2011; 208:519-533.
18. Parthasarathi K, Ichimura H, Quadri S, Issekutz A and Bhattacharya J. Mitochondrial reactive oxygen species regulate spatial profile of proinflammatory responses in lung venular capillaries. The Journal of Immunology. 2002; 169:7078-7086.
19. Brigelius-Flohe R and Flohe L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal. 2011; 15:2335-2381.
20. Anisimov VN, Egorov MV, Krasilshchikova MS, Lyamzaev KG, Manskikh VN, Moshkin MP, Novikov EA, Popovich IG, Rogovin KA, Shabalina IG, Shekarova ON, Skulachev MV, Titova TV, et al. Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents. Aging (Albany NY). 2011; 3:1110-1119.
21. Pelletier M, Lepow TS, Billingham LK, Murphy MP and Siegel RM. New tricks from an old dog: mitochondrial redox signaling in cellular inflammation. Semin Immunol. 2012; 24:384-392.
22. Popova EN, Pletjushkina OY, Dugina VB, Domnina LV, Ivanova OY, Izyumov DS, Skulachev VP and Chernyak BV. Scavenging of reactive oxygen species in mitochondria induces myofibroblast differentiation. Antioxid Redox Signal. 2010; 13:1297-1307.
23. Roginsky VA, Tashlitsky VN and Skulachev VP. Chain-breaking antioxidant activity of reduced forms of mitochondria-targeted quinones, a novel type of geroprotectors. Aging (Albany NY). 2009; 1:481-489.
24. Skulachev VP. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress. Biochem Biophys Res Commun. 2013; 441:275-279.
25. Smith RA, Hartley RC and Murphy MP. Mitochondriatargeted small molecule therapeutics and probes. Antioxid Redox Signal. 2011; 15:3021-3038.
26. Skulachev VP, Antonenko YN, Cherepanov DA, Chernyak BV, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Pletjushkina OY, Roginsky VA, Rokitskaya TI, Severin FF, et al. Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim Biophys Acta. 2010; 1797:878-889.
27. Plotnikov EY, Chupyrkina AA, Pevzner IB, Isaev NK and Zorov DB. Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria. Biochim Biophys Acta. 2009; 1792:796-803.
28. Plotnikov EY, Silachev DN, Jankauskas SS, Rokitskaya TI, Chupyrkina AA, Pevzner IB, Zorova LD, Isaev NK, Antonenko YN, Skulachev VP and Zorov DB. Mild uncoupling of respiration and phosphorylation as a mechanism providing nephro- and neuroprotective effects of penetrating cations of the SkQ family. Biochemistry (Mosc). 2012; 77:1029-1037.
29. Plotnikov EY, Morosanova MA, Pevzner IB, Zorova LD, Manskikh VN, Pulkova NV, Galkina SI, Skulachev VP and Zorov DB. Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection. Proc Natl Acad Sci U S A. 2013; 110:E3100-3108.
30. Markovets AM, Fursova AZ and Kolosova NG. Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression. PLoS One. 2011; 6:e21682.
31. Markovets AM, Saprunova VB, Zhdankina AA, Fursova A, Bakeeva LE and Kolosova NG. Alterations of retinal pigment epithelium cause AMD-like retinopathy in senescenceaccelerated OXYS rats. Aging (Albany NY). 2011; 3:44-54.
32. Vays VB, Eldarov CM, Vangely IM, Kolosova NG, Bakeeva LE and Skulachev VP. Antioxidant SkQ1 delays sarcopeniaassociated damage of mitochondrial ultrastructure. Aging (Albany NY). 2014; 6:140-148.
33. Demianenko I, Vasilieva T, Domnina L, Dugina V, Egorov M, Ivanova OY, Ilinskaya O, Pletjushkina O, Popova E and Sakharov I. Novel mitochondria-targeted antioxidants,"Skulachev-ion" derivatives, accelerate dermal wound healing in animals. Biochemistry (Moscow). 2010; 75:274-280.
34. Obukhova LA, Skulachev VP and Kolosova NG. Mitochondriatargeted antioxidant SkQ1 inhibits age-dependent involution of the thymus in normal and senescence-prone rats. Aging (Albany NY). 2009; 1:389-401.
35. Kolosova NG, Stefanova NA, Muraleva NA and Skulachev VP. The mitochondria-targeted antioxidant SkQ1 but not Nacetylcysteine reverses aging-related biomarkers in rats. Aging (Albany NY). 2012; 4:686-694.
36. Bruunsgaard H, Skinhoj P, Pedersen AN, Schroll M and Pedersen BK. Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clinical and experimental immunology. 2000; 121:255-260.
37. Chung HY, Sung B, Jung KJ, Zou Y and Yu BP. The molecular inflammatory process in aging. Antioxid Redox Signal. 2006; 8:572-581.
38. Dandona P, Aljada A and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends in immunology. 2004; 25:4-7.
39. Ahn K, Pan S, Beningo K and Hupe D. A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cells. Life Sci. 1995; 56:2331-2341.
40. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F and Esmon CT. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009; 15:1318-1321.
41. Galley HF, Blaylock MG, Dubbels AM and Webster NR. Variability in E-selectin expression, mRNA levels and sE-selectin release between endothelial cell lines and primary endothelial cells. Cell Biol Int. 2000; 24:91-99.
42. McMullen CB, Fleming E, Clarke G and Armstrong MA. The role of reactive oxygen intermediates in the regulation of cytokine-induced ICAM-1 surface expression on endothelial cells. Mol Cell Biol Res Commun. 2000; 3:231-237.
43. Ikeda M, Schroeder KK, Mosher LB, Woods CW and Akeson AL. Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes. J Invest Dermatol. 1994; 103:791-796.
44. Jiang MZ, Tsukahara H, Hayakawa K, Todoroki Y, Tamura S, Ohshima Y, Hiraoka M and Mayumi M. Effects of antioxidants and NO on TNF-alpha-induced adhesion molecule expression in human pulmonary microvascular endothelial cells. Respir Med. 2005; 99:580-591.
45. Yen FL, Tsai MH, Yang CM, Liang CJ, Lin CC, Chiang YC, Lee HC, Ko HH and Lee CW. Curcumin nanoparticles ameliorate ICAM-1 expression in TNF-alpha-treated lung epithelial cells through p47 (phox) and MAPKs/AP-1 pathways. PLoS One. 2013; 8:e63845.
46. Chernyak BV, Antonenko YN, Domnina LV, Ivanova OY, Lyamzaev KG, Pustovidko AV, Rokitskaya TI, Severina, II, Simonyan RA, Trendeleva TA and Zvyagilskaya RA. Novel penetrating cations for targeting mitochondria. Curr Pharm Des. 2013; 19:2795-2806.
47. Muro S, Wiewrodt R, Thomas A, Koniaris L, Albelda SM, Muzykantov VR and Koval M. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci. 2003; 116:1599-1609.
48. Lawson C and Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep. 2009; 61:22-32.
49. Muro S, Gajewski C, Koval M and Muzykantov VR. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood. 2005; 105:650-658.
50. Marlin SD and Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte functionassociated antigen 1 (LFA-1). Cell. 1987; 51:813-819.
51. Tilstra JS, Clauson CL, Niedernhofer LJ and Robbins PD. NFkappaB in Aging and Disease. Aging and disease. 2011; 2:449- 465.
52. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W and Haegeman G. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochemical pharmacology. 2002; 64:963-970.
53. Paterson RL, Galley HF and Webster NR. The effect of Nacetylcysteine on nuclear factor-kappa B activation, interleukin- 6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Critical care medicine. 2003; 31:2574-2578.
54. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panouraia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC and Salvioli S. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007; 128:92-105.
55. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med. 2005; 38:1278-1295.
56. Puddu P, Puddu GM, Galletti L, Cravero E and Muscari A. Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis. Cardiology. 2005; 103:137-141.
57. Cybulsky MI and Gimbrone MA, Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991; 251:788-791.
58. Kutuk O and Basaga H. Inflammation meets oxidation: NFkappaB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med. 2003; 9:549-557.
59. Nageh MF, Sandberg ET, Marotti KR, Lin AH, Melchior EP, Bullard DC and Beaudet AL. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 1997; 17:1517-1520.
60. Oh GT, Choi JH, Hong JJ, Kim DY, Lee SB, Kim JR, Lee CH, Hyun BH, Oh SR, Bok SH and Jeong TS. Dietary hematein ameliorates fatty streak lesions in the rabbit by the possible mechanism of reducing VCAM-1 and MCP-1 expression. Atherosclerosis. 2001; 159:17-26.
61. Zarbock A and Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol. 2008; 172:1-7.
62. Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. Science. 1998; 281:1305-1308.
63. Sabio G and Davis RJ. TNF and MAP kinase signalling pathways. Semin Immunol.
64. Ghosh S and Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002; 109 Suppl:S81-96.
65. Hacker H and Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE. 2006; 2006:re13.
66. Rahman A and Fazal F. Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration. Antioxid Redox Signal. 2009; 11:823-839.
67. Beinke S and Ley SC. Functions of NF-kappaB1 and NFkappaB2 in immune cell biology. Biochem J. 2004; 382:393-409.
68. Catalan U, Fernandez-Castillejo S, Pons L, Heras M, Aragones G, Angles N, Morello JR and Sola R. Alpha-tocopherol and BAY 11-7082 reduce vascular cell adhesion molecule in human aortic endothelial cells. J Vasc Res. 2012; 49:319-328.
69. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A and Ungvari Z. Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol. 2006; 291:H1694-1699.
70. Mukhopadhyay P, Horvath B, Zsengeller Z, Batkai S, Cao Z, Kechrid M, Holovac E, Erdelyi K, Tanchian G, Liaudet L, Stillman IE, Joseph J, Kalyanaraman B, et al. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med. 2012; 53:1123-1138.
71. Schreck R, Albermann K and Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun. 1992; 17:221-237.
72. Pantano C, Reynaert NL, van der Vliet A and Janssen- Heininger YM. Redox-sensitive kinases of the nuclear factorkappaB signaling pathway. Antioxid Redox Signal. 2006; 8:1791- 1806.
73. Kabe Y, Ando K, Hirao S, Yoshida M and Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal. 2005; 7:395-403.
74. Schreck R, Rieber P and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. Embo J. 1991; 10:2247-2258.
75. Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Havard L, Merville MP and Bours V. Reactive oxygen intermediatedependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol. 1999; 19:1950-1960.
76. Park HS, Jung HY, Park EY, Kim J, Lee WJ and Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 2004; 173:3589-3593.
77. Ryan KA, Smith MF, Jr., Sanders MK and Ernst PB. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect Immun. 2004; 72:2123-2130.
78. Sanlioglu S, Williams CM, Samavati L, Butler NS, Wang G, McCray PB, Jr., Ritchie TC, Hunninghake GW, Zandi E and Engelhardt JF. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NFkappa B. J Biol Chem. 2001; 276:30188-30198.
79. Sulciner DJ, Irani K, Yu ZX, Ferrans VJ, Goldschmidt-Clermont P and Finkel T. rac1 regulates a cytokine-stimulated, redoxdependent pathway necessary for NF-kappaB activation. Mol Cell Biol. 1996; 16:7115-7121.
80. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M and Kikugawa K. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J. 2003; 22:3356-3366.
81. Schmidt KN, Amstad P, Cerutti P and Baeuerle PA. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol. 1995; 2:13-22.
82. Manna SK, Zhang HJ, Yan T, Oberley LW and Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem. 1998; 273:13245-13254.
83. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408:239-247.
84. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008; 7:3344-3354.
85. Nuhrenberg TG, Voisard R, Fahlisch F, Rudelius M, Braun J, Gschwend J, Kountides M, Herter T, Baur R, Hombach V, Baeuerle PA and Zohlnhofer D. Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. FASEB J. 2005; 19:246-248.
86. Chen WQ, Zhong L, Zhang L, Ji XP, Zhang M, Zhao YX, Zhang C and Zhang Y. Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels. Br J Pharmacol. 2009; 156:941-951.
87. Leontieva OV and Blagosklonny MV. Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression. Aging. 2011; 3:1078-1091.
88. Shafique E, Choy WC, Liu Y, Feng J, Cordeiro B, Lyra A, Arafah M, Yassin-Kassab A, Zanetti AV, Clements RT, Bianchi C, Benjamin LE, Sellke FW, et al. Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK. Aging. 2013; 5:515-530.
89. Coleman PR, Chang G, Hutas G, Grimshaw M, Vadas MA and Gamble JR. Age-associated stresses induce an anti-inflammatory senescent phenotype in endothelial cells. Aging. 2013; 5:913- 924.
90. Borodkina A, Shatrova A, Abushik P, Nikolsky N and Burova E. Interaction between ROS dependent DNA damage, mitochondria and p38 MAPK underlies senescence of human adult stem cells. Aging. 2014; 6:481-495.
91. Kris-Etherton PM, Lichtenstein AH, Howard BV, Steinberg D and Witztum JL. Antioxidant vitamin supplements and cardiovascular disease. Circulation. 2004; 110:637-641.
92. Nunez-Cordoba JM and Martinez-Gonzalez MA. Antioxidant vitamins and cardiovascular disease. Curr Top Med Chem. 2011; 11:1861-1869.
93. Rocha M, Apostolova N, Hernandez-Mijares A, Herance R and Victor VM. Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics. Current Medicinal Chemistry. 2010; 17:3827-3841.
94. Galkin, II, Pletjushkina OY, Zinovkin RA, Zakharova VV, Birjukov IS, Chernyak BV and Popova EN. Mitochondria-Targeted Antioxidants Prevent TNFalpha-Induced Endothelial Cell Damage. Biochemistry Biokhimiia. 2014; 79:124-130.